ANY - AMC DNN NGA and ALT among premarket gainers
Intec Pharma Ltd (NTEC) +142% on announcing merger agreement with Decoy Biosystems.Check-Cap Ltd. (CHEK) +113% after receiving FDA IDE approval for pivotal study of C-Scan®.Acer Therapeutics (ACER) +67%.Shaw Communications (SJR) +55% as Rogers to acquire the company in C$26B deal.Farmmi (FAMI) +105% on new multi-product U.S. export order.Ocuphire Pharma (OCUP) +37% on positive Nyxol data in reversal of mydriasis.Luokung Technology (LKCO) +34%.GenMark Diagnostics (GNMK) +29% as Roche to buy the company in $1.8B deal.AzurRx BioPharma (AZRX) +20%.Extended Stay America (STAY) +17% as Blackstone and Starwood Capital to buy the company in $6B deal.Savara (SVRA) +17%.Sphere 3D (ANY) +14%.Cellect Biotechnology (APOP) +14%.Denison Mines Corp. (DNN) +14% after inclusion into TSX index.Northern Genesis Acquisition Corp. (NGA) +13%.Yalla Group Limited (YALA) +13% on Q4 results.ADiTx Therapeutics (ADTX) +14%.Altimmune (ALT) +13% on preclinical data for its single dose intranasal COVID-19 vaccine candidate.Oriental Culture Holding (OCG) +12%.Navidea Biopharmaceuticals (NAVB) +11%.Histogen (HSTO) +14%.AMC Entertainment Holdings (AMC) +11%.BioXcel Therapeutics (BTAI) +11%. as its BXCL501 nabs accelerated review
For further details see:
AMC, DNN, NGA and ALT among premarket gainers